Skip to main content
. Author manuscript; available in PMC: 2020 Jul 8.
Published in final edited form as: Biom J. 2019 Feb 20;61(4):902–917. doi: 10.1002/bimj.201700323

Figure 1.

Figure 1

Precision medicine in oncology relies on biomarkers deriving from a diverse array of sources. Treatment decisions may be based on clinical characteristics of the patient and tumor (such as histopathology and cytopathology), genomic-variants (such as somatic mutations), or imaging features that describe a tumor tissue’s density, morphology, or texture.